Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, January 2023-June 2024

被引:0
|
作者
Namageyo-Funa, Apophia [1 ]
Greene, Sharon A. [1 ]
Henderson, Elizabeth [2 ]
Traore, Mohamed A. [3 ]
Shaukat, Shahzad [3 ]
Bigouette, John Paul [1 ]
Jorba, Jaume [2 ]
Wiesen, Eric [1 ]
Bolu, Omotayo [1 ]
Diop, Ousmane M.
Burns, Cara C. [2 ]
Wassilak, Steven G. F. [1 ]
机构
[1] CDC, Ctr Global Hlth, Global Immunizat Div, Atlanta, GA 30329 USA
[2] CDC, Natl Ctr Immunizat & Resp Dis, Div Viral Dis, Atlanta, GA USA
[3] WHO, Polio Eradicat Dept, Geneva, Switzerland
来源
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Circulating vaccine-derived polioviruses (cVDPVs) can emerge and lead to outbreaks of paralytic polio as well as asymptomatic transmission in communities with a high percentage of undervaccinated children. Using data from the World Health Organization Polio Information System and Global Polio Laboratory Network, this report describes global polio outbreaks due to cVDPVs during January 2023-June 2024 and updates previous reports. During the reporting period, 74 cVDPV outbreaks were detected in 39 countries or areas (countries), predominantly in Africa. Among these 74 cVDPV outbreaks, 47 (64%) were new outbreaks, detected in 30 (77%) of the 39 countries. Three countries reported cVDPV type 1 (cVDPV1) outbreaks and 38 countries reported cVDPV type 2 (cVDPV2) outbreaks; two of these countries reported cocirculating cVDPV1 and cVDPV2. In the 38 countries with cVDPV2 transmission, 70 distinct outbreaks were reported. In 15 countries, cVDPV transmission has lasted >1 year into 2024. In Nigeria and Somalia, both countries with security- compromised areas, persistent cVDPV2 transmission has spread to neighboring countries. Delayed implementation of outbreak response campaigns and low-quality campaigns have resulted in further international spread. Countries can control cVDPV outbreaks with timely allocation of resources to implement prompt, high-quality responses after outbreak confirmation. Stopping all cVDPV transmission requires effectively increasing population immunity by overcoming barriers to reaching children.
引用
收藏
页码:909 / 916
页数:8
相关论文
共 50 条
  • [31] Update on Vaccine-Derived Polioviruses - Worldwide, July 2012-December 2013
    Diop, Ousmane M.
    Burns, Cara C.
    Wassilak, Steven G.
    Kew, Olen M.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2014, 63 (11): : 242 - 248
  • [32] Vaccine-derived poliovirus serotype 2 outbreaks and response in the Democratic Republic of the Congo, 2017-2021
    Alleman, Mary M.
    Jorba, Jaume
    Riziki, Yogolelo
    Henderson, Elizabeth
    Mwehu, Anicet
    Seakamela, Lerato
    Howard, Wayne
    Mbule, Albert Kadiobo
    Nsamba, Renee Ntumbannji
    Djawe, Kpandja
    Yapi, Moise Desire
    Mengouo, Marcellin Nimpa
    Gumede, Nicksy
    Ndoutabe, Modjirom
    Kfutwah, Anfumbom K. W.
    Senouci, Kamel
    Burns, Cara C.
    VACCINE, 2023, 41 : A35 - A47
  • [33] Modeling the spread of circulating vaccine-derived poliovirus type 2 outbreaks and interventions: A case study of Nigeria
    Sun, Yuming
    Keskinocak, Pinar
    Steimle, Lauren N.
    Kovacs, Stephanie D.
    Wassilak, Steven G.
    VACCINE: X, 2024, 18
  • [34] Reemergence of recombinant vaccine-derived poliovirus outbreak in Madagascar
    Rakoto-Andrianarivelo, Mala
    Gumede, Nicksy
    Jegouic, Sophie
    Balanant, Jean
    Andriamamonjy, Seta N.
    Rabemanantsoa, Sendraharimanana
    Birmingham, Maureen
    Randriamanalina, Bakolalao
    Nkolomoni, Leon
    Venter, Marietjie
    Schoub, Barry D.
    Delpeyroux, Francis
    Reynes, Jean-Marc
    JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (10): : 1427 - 1435
  • [36] Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication
    Minor, Philip
    VACCINE, 2009, 27 (20) : 2649 - 2652
  • [37] Vaccine-derived poliovirus cases exceed wild types
    Burki, Talha
    LANCET INFECTIOUS DISEASES, 2019, 19 (02): : 140 - 140
  • [38] Implications of a Circulating Vaccine-Derived Poliovirus in Nigeria.
    Jenkins, Helen E.
    Aylward, R. Bruce
    Gasasira, Alex
    Donnelly, Christl A.
    Mwanza, Michael
    Corander, Jukka
    Garnier, Sandra
    Chauvin, Claire
    Abanida, Emmanuel
    Pate, Muhammad Ali
    Adu, Festus
    Baba, Marycelin
    Grassly, Nicholas C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (25): : 2360 - 2369
  • [39] Risk Assessments for Type 1 Wild Poliovirus and Type 2 Vaccine-Derived Poliovirus Importation and Transmission - China, 2023
    Kang, Wei
    Fan, Chunxiang
    Song, Yifan
    Zhang, Zhaonan
    Wang, Xiaoqi
    Wang, Miao
    Ma, Jing
    Chen, Mulei
    Yang, Yuzhen
    Wen, Yi
    Cao, Lei
    Rodewald, Lance
    Wang, Fuzhen
    Yin, Zundong
    Wen, Ning
    Yang, Hong
    CHINA CDC WEEKLY, 2024, 6 (42):
  • [40] Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs
    Tebbens, Radboud J. Duintjer
    Thompson, Kimberly M.
    BMC INFECTIOUS DISEASES, 2015, 15